|
Volumn 68, Issue 4, 2013, Pages 972-974
|
Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma
|
Author keywords
HBV; Hepatic transplantation; HIV antiviral pharmacology; Immunosuppression
|
Indexed keywords
ALPHA FETOPROTEIN;
EFAVIRENZ;
EMTRICITABINE;
HEPATITIS B SURFACE ANTIBODY;
MARAVIROC;
PREDNISOLONE;
TACROLIMUS;
TENOFOVIR;
ACUTE KIDNEY FAILURE;
ADULT;
ANEMIA;
ANTIVIRAL THERAPY;
AREA UNDER THE CURVE;
CASE REPORT;
CD4 LYMPHOCYTE COUNT;
CENTRAL NERVOUS SYSTEM DISEASE;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG HALF LIFE;
ECHOGRAPHY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
LAPAROSCOPY;
LETTER;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FUNCTION TEST;
LIVER TRANSPLANTATION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MIXED INFECTION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANTI-HIV AGENTS;
CARCINOMA, HEPATOCELLULAR;
CYCLOHEXANES;
DRUG INTERACTIONS;
HEPATITIS B;
HIV INFECTIONS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PLASMA;
TACROLIMUS;
TREATMENT OUTCOME;
TRIAZOLES;
|
EID: 84875242373
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dks486 Document Type: Letter |
Times cited : (7)
|
References (5)
|